Sustained response to vemurafenib in a low grade serous ovarian cancer with a BRAF V600E mutation.
about
Somatic mutations in solid tumors: a spectrum at the service of diagnostic armamentarium or an indecipherable puzzle? The morphological eyes looking for BRAF and somatic molecular detections on cyto-histological samplesUpdate on rare epithelial ovarian cancers: based on the Rare Ovarian Tumors Young Investigator Conference.The roles of pathology in targeted therapy of women with gynecologic cancers.Targeting the mitogen-activated protein kinase pathway in low-grade serous carcinoma of the ovary.Dramatic clinical response following dabrafenib and trametinib therapy in a heavily pretreated low grade serous ovarian carcinoma patient with a BRAF V600E mutation
P2860
Sustained response to vemurafenib in a low grade serous ovarian cancer with a BRAF V600E mutation.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Sustained response to vemurafe ...... er with a BRAF V600E mutation.
@en
Sustained response to vemurafe ...... er with a BRAF V600E mutation.
@nl
type
label
Sustained response to vemurafe ...... er with a BRAF V600E mutation.
@en
Sustained response to vemurafe ...... er with a BRAF V600E mutation.
@nl
prefLabel
Sustained response to vemurafe ...... er with a BRAF V600E mutation.
@en
Sustained response to vemurafe ...... er with a BRAF V600E mutation.
@nl
P2093
P2860
P1476
Sustained response to vemurafe ...... er with a BRAF V600E mutation.
@en
P2093
Caroline Rousseau
Hélène Blons
Laure Chauvenet
Marie-Aude Lefrère-Belda
Pierre Combe
Stéphane Oudard
P2860
P2888
P304
P356
10.1007/S10637-015-0297-4
P577
2015-10-21T00:00:00Z